4 01/06/2024 31/05/2025 2025-05-31 false false false false false false false true false false true false false false false false true false No description of principal activities is disclosed 2024-06-01 Sage Accounts Production 25.0 - FRS102_2025 xbrli:pure xbrli:shares iso4217:GBP 11382521 2024-06-01 2025-05-31 11382521 2025-05-31 11382521 2024-05-31 11382521 2023-06-01 2024-05-31 11382521 2024-05-31 11382521 2023-05-31 11382521 core:OnerousContractsExcludingVacantProperties 2024-06-01 2025-05-31 11382521 bus:RegisteredOffice 2024-06-01 2025-05-31 11382521 bus:LeadAgentIfApplicable 2024-06-01 2025-05-31 11382521 bus:Director1 2024-06-01 2025-05-31 11382521 bus:Director2 2024-06-01 2025-05-31 11382521 bus:Director3 2024-06-01 2025-05-31 11382521 bus:Director4 2024-06-01 2025-05-31 11382521 core:WithinOneYear 2025-05-31 11382521 core:WithinOneYear 2024-05-31 11382521 core:ShareCapital 2023-06-01 2024-05-31 11382521 core:RetainedEarningsAccumulatedLosses 2023-06-01 2024-05-31 11382521 core:ShareCapital 2024-06-01 2025-05-31 11382521 core:RetainedEarningsAccumulatedLosses 2024-06-01 2025-05-31 11382521 core:ShareCapital 2025-05-31 11382521 core:ShareCapital 2024-05-31 11382521 core:RetainedEarningsAccumulatedLosses 2025-05-31 11382521 core:RetainedEarningsAccumulatedLosses 2024-05-31 11382521 core:ShareCapital 2023-05-31 11382521 core:RetainedEarningsAccumulatedLosses 2023-05-31 11382521 core:PreviouslyStatedAmount core:ShareCapital 2025-05-31 11382521 bus:Director1 2024-05-31 11382521 bus:Director1 2023-05-31 11382521 bus:Director1 2024-05-31 11382521 bus:Director1 2023-06-01 2024-05-31 11382521 bus:SmallEntities 2024-06-01 2025-05-31 11382521 bus:AuditExemptWithAccountantsReport 2024-06-01 2025-05-31 11382521 bus:SmallCompaniesRegimeForAccounts 2024-06-01 2025-05-31 11382521 bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 11382521 bus:FullAccounts 2024-06-01 2025-05-31 11382521 core:ComputerEquipment 2024-06-01 2025-05-31 11382521 core:ComputerEquipment 2025-05-31 11382521 core:ComputerEquipment 2024-05-31
Company registration number: 11382521
Beauty&Vitality Limited
Unaudited filleted financial statements
31 May 2025
Beauty&Vitality Limited
Contents
Directors and other information
Accountants report
Statement of financial position
Statement of changes in equity
Notes to the financial statements
Beauty&Vitality Limited
Directors and other information

| Directors | Christopher Barrow
|  | Lysa Hardy
|  | Nicola Silverlock
|  | Daniel Rippon
| Company number | 11382521
| Registered office | Vaughan Chambers
|  | Vaughan Road
|  | Harpenden
|  | AL5 4EE
| Accountants | Hicks and Company
|  | Chartered Accountants
|  | Vaughan Chambers
|  | Vaughan Road
|  | Harpenden
|  | AL5 4EE

Beauty&Vitality Limited
Chartered accountants report to the board of directors on the preparation of the
unaudited statutory financial statements of Beauty&Vitality Limited
Year ended 31 May 2025
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Beauty&Vitality Limited for the year ended 31 May 2025 which comprise the statement of financial position, statement of changes in equity and related notes from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com /en/members/regulations-standards-and-guidance/.
This report is made solely to the board of directors of Beauty&Vitality Limited, as a body, in accordance with the terms of our engagement letter dated 27 February 2025. Our work has been undertaken solely to prepare for your approval the financial statements of Beauty&Vitality Limited and state those matters that we have agreed to state to the board of directors of Beauty&Vitality Limited as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Beauty&Vitality Limited and its board of directors as a body for our work or for this report.
It is your duty to ensure that Beauty&Vitality Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Beauty&Vitality Limited. You consider that Beauty&Vitality Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of Beauty&Vitality Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Hicks and Company
Chartered Accountants
Vaughan Chambers
Vaughan Road
Harpenden
AL5 4EE
24 February 2026
Beauty&Vitality Limited
Statement of financial position
31 May 2025

|  |  | 2025 |  |  |  | 2024 |  |
|  | Note | £ |  | £ |  | £ |  | £
Fixed assets |  |  |  |  |  |  |  |  |
Tangible assets |  | 5 | 1 |  |  |  | 1 |  |
|  |  | _______ |  |  |  | _______ |  |
|  |  |  |  | 1 |  |  |  | 1
Current assets |  |  |  |  |  |  |  |  |
Stocks |  |  | 500 |  |  |  | 7,803 |  |
Debtors |  | 6 | 167 |  |  |  | 4,050 |  |
Cash at bank and in hand |  |  | 3,665 |  |  |  | 8,435 |  |
|  |  | _______ |  |  |  | _______ |  |
|  |  | 4,332 |  |  |  | 20,288 |  |
Creditors: amounts falling due |  |  |  |  |  |  |  |  |
within one year |  | 7 | ( 2,106) |  |  |  | ( 2,832) |  |
|  |  | _______ |  |  |  | _______ |  |
Net current assets |  |  |  |  | 2,226 |  |  |  | 17,456
|  |  |  |  | _______ |  |  |  | _______
Total assets less current liabilities |  |  |  |  | 2,227 |  |  |  | 17,457
|  |  |  |  | _______ |  |  |  | _______
Net assets |  |  |  |  | 2,227 |  |  |  | 17,457
|  |  |  |  | _______ |  |  |  | _______
Capital and reserves |  |  |  |  |  |  |  |  |
Called up share capital |  |  |  |  | 198,950 |  |  |  | 194,950
Profit and loss account |  |  |  |  | ( 196,723) |  |  |  | ( 177,493)
|  |  |  |  | _______ |  |  |  | _______
Shareholders funds |  |  |  |  | 2,227 |  |  |  | 17,457
|  |  |  |  | _______ |  |  |  | _______

For the year ending 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 24 February 2026 , and are signed on behalf of the board by:
Christopher Barrow
Director
Company registration number: 11382521
Beauty&Vitality Limited
Statement of changes in equity
Year ended 31 May 2025

|  | Called up share capital |  | Profit and loss account | Total |  |  |  |  |
|  | £ |  | £ | £ |  |  |  |  |
At 1 June 2023 |  | 200 |  | ( 103,737) | ( 103,537) |  |  |  |  |
Loss for the year |  |  |  | ( 73,756) | ( 73,756) |  |  |  |  |
|  | _______ |  | _______ | _______ |  |  |  |  |
Total comprehensive income for the year |  | - |  | ( 73,756) | ( 73,756) |  |  |  |  |
Issue of shares |  | 194,750 |  |  | 194,750 |  |  |  |  |
|  | _______ |  | _______ | _______ |  |  |  |  |
Total investments by and distributions to owners |  | 194,750 |  | - | 194,750 |  |  |  |  |
|  | _______ |  | _______ | _______ |  |  |  |  |
At 31 May 2024 and 1 June 2024 |  | 194,950 |  | ( 177,493) | 17,457 |  |  |  |  |
Loss for the year |  |  |  | ( 19,230) | ( 19,230) |  |  |  |  |
|  | _______ |  | _______ | _______ |  |  |  |  |
Total comprehensive income for the year |  | - |  | ( 19,230) | ( 19,230) |  |  |  |  |
Issue of shares |  | 4,000 |  |  | 4,000 |  |  |  |  |
|  | _______ |  | _______ | _______ |  |  |  |  |
Total investments by and distributions to owners |  | 4,000 |  | - | 4,000 |  |  |  |  |
|  | _______ |  | _______ | _______ |  |  |  |  |
At 31 May 2025 |  | 198,950 |  | ( 196,723) | 2,227 |  |  |  |  |
|  | _______ |  | _______ | _______ |  |  |  |  |

Beauty&Vitality Limited
Notes to the financial statements
Year ended 31 May 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Vaughan Chambers, Vaughan Road, Harpenden, AL5 4EE.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Turnover
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively.
Tangible assets
tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses.
Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

| Computer equipment | - | 50 % | straight line

If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
Debt instruments are subsequently measured at amortised cost.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 4 (2024: 4 ).
5. Tangible assets

|  | Computer equipment | Total |  |  |  |  |
|  | £ | £ |  |  |  |  |
| Cost |  |  |  |  |  |  |
| At 1 June 2024 and 31 May 2025 | 733 | 733 |  |  |  |  |
|  | _______ | _______ |  |  |  |  |
| Depreciation |  |  |  |  |  |  |
| At 1 June 2024 and 31 May 2025 | 732 | 732 |  |  |  |  |
|  | _______ | _______ |  |  |  |  |
| Carrying amount |  |  |  |  |  |  |
| At 31 May 2025 | 1 | 1 |  |  |  |  |
|  | _______ | _______ |  |  |  |  |
| At 31 May 2024 | 1 | 1 |  |  |  |  |
|  | _______ | _______ |  |  |  |  |

6. Debtors

|  |  | 2025 | 2024
|  |  | £ | £
| Other debtors |  | 167 | 4,050
|  |  | _______ | _______

7. Creditors: amounts falling due within one year

|  |  | 2025 | 2024
|  |  | £ | £
| Bank loans and overdrafts |  | 147 | 138
| Trade creditors |  | 396 | 1,914
| Social security and other taxes |  | 753 | -
| Other creditors |  | 810 | 780
|  |  | _______ | _______
|  |  | 2,106 | 2,832
|  |  | _______ | _______

8. Directors advances, credits and guarantees

| During the year the directors entered into the following advances and credits with the company: |  |  |  |  |  |
2025 |  |  |  |  |  |  |
|  | Balance brought forward | Advances /(credits) to the directors | Amounts repaid | Balance o/standing |  |
|  | £ | £ | £ | £ |  |
| Christopher Barrow | 195 | ( 195) | - | - |  |
|  | _______ | _______ | _______ | _______ |  |
2024 |  |  |  |  |  |  |
|  | Balance brought forward | Advances /(credits) to the directors | Amounts repaid | Balance o/standing |  |
|  | £ | £ | £ | £ |  |
| Christopher Barrow | ( 70,304) | - | 70,499 | 195 |  |
|  | _______ | _______ | _______ | _______ |  |